Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Arrowhead Pharmaceuticals history
Arrowhead Pharmaceuticals company history timeline
Doctor Ferrari has been serving as the Editor-in-Chief for “Biomedical Microdevices: BioMEMS and Biomedical Nanotechnology” since 1997.
In 2005, Doctor Anzalone formed and served as CEO of the Benet Group LLC, a private equity firm focused on creating and building new nano-biotechnology companies from university-generated science.
Doctor Christopher Anzalone has been President, Chief Executive Officer and Director of the Company since December 1, 2007.
Kenneth A. Myszkowski, Chief Financial Officer, joined Arrowhead in 2009.
He has been a director of the Company since 2010.
O’Brien co-founded the law firm O’Brien Gould PLLC which joined Holland & Knight in 2011.
Most recently he was Senior Vice President, CFO of Calithera Bioscience where he completed over $106 million in equity financing including the company’s $80 million IPO in October 2014.
Patrick C. O’Brien, General Counsel, joined the Company in December 2014.
She joined Shire Pharmaceuticals in 2016 through the acquisition of Baxalta and was Global Head of New Product Planning and Device Strategy.
Tracie Oliver, Chief Commercial Officer, joined Arrowhead in June 2022.
Rate Arrowhead Pharmaceuticals' efforts to communicate its history to employees.
Arrowhead Pharmaceuticals jobs
Do you work at Arrowhead Pharmaceuticals?
Is Arrowhead Pharmaceuticals' vision a big part of strategic planning?
Arrowhead Pharmaceuticals history FAQs
Zippia gives an in-depth look into the details of Arrowhead Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Arrowhead Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Arrowhead Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Arrowhead Pharmaceuticals. The data presented on this page does not represent the view of Arrowhead Pharmaceuticals and its employees or that of Zippia.
Arrowhead Pharmaceuticals may also be known as or be related to ARROWHEAD RESEARCH CORP, Arrowhead Pharmaceuticals, Arrowhead Pharmaceuticals Inc, Arrowhead Pharmaceuticals Inc. and Arrowhead Pharmaceuticals, Inc.